A cancer vaccine generated using the cells left over after tumour removal surgery could help to keep patients from ...

Moderna is the only company in its peer group burning cash at an alarming rate. Click here to read more about MRNA stock and ...

(MENAFN) Russia’s Gamaleya Research Institute, known for developing the Sputnik V COVID-19 vaccine, is close to gaining regulatory approval for a personalized mRNA cancer vaccine. According to ...

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has launched a consultation on regulatory guidance for ...

The Cancer Vaccines Market is witnessing significant expansion, driven by rising cancer prevalence and advancements in ...

The fusion of mRNA technology with AI has laid the foundation for ushering in a new era of cancer care. However, conducting ...

The latest guidance reduction was the second time in the last six months that the firm has revised its forecast in a negative ...

Clinical trial using the same technology as Covid-19 vaccines is designed to fight colorectal cancer and prevent it from ...

Modern medicine is helping clinicians tailor cancer treatments for individuals and Birmingham researchers are at the ...

A cancer patient who has become the first person in Wales to trial a new type of vaccine says she "can't believe how lucky" ...

Breast cancer cases in Americans under 45 years old dramatically increased after the introduction of mRNA COVID-19 vaccines, from approximately 26,000 in 2019-2022 to 297,000 in 2023, a nearly 1,000% ...